Can light influence energy processes in the brain?
Could light influence brain function and its mitochondria? Researchers are investigating changes in cellular metabolism and oxygenation. To interpret the findings, we need to distinguish three things: a proposed mechanism, a measured biological marker and a meaningful improvement in how a person functions. [2][5][6]
Which questions does this article answer?
- How can light pass through the skull into the brain?
- What does light do to mitochondria in neurons?
- Does photobiomodulation increase ATP production in the brain?
- Which wavelength is most suitable for brain stimulation?
- Can light improve memory, attention and concentration?
- What has research found about brain fog and fatigue?
- Can light support neuroplasticity and the formation of new neurons?
- Does photobiomodulation affect brain blood flow and oxygenation?
- What have studies found in Alzheimer’s and Parkinson’s disease?
- Does photobiomodulation help with depression and anxiety?
- Can it support recovery after concussion or stroke?
- How are mitochondria, microglia and neuroinflammation connected?
- How do helmets, nasal applicators and LED panels differ?
- Is it safe to use an infrared laser on the head?
- How long and how often is light applied in research?
Select a question to scroll to its answer within this article.
Full menu of the light research series — expand
What does brain energy mean, and what is ATP for?
The brain remains active at rest. Neurons maintain electrical differences across their membranes, transmit signals and restore their internal environment. Brain energy therefore means more than feeling refreshed or being able to concentrate. It is also essential for the everyday operation of cells during sleep. [2]
ATP, adenosine triphosphate, is an immediately usable energy carrier inside cells. It is continually produced and consumed by enzyme activity, transport processes and maintenance of ion balance. A substantial proportion of ATP is made in mitochondria. [2]
The respiratory chain uses energy from nutrient metabolism to create a proton gradient across the inner mitochondrial membrane. This gradient drives ATP synthase. Oxygen accepts electrons at the end of the chain. Oxygen, suitable nutrients, functioning enzymes and intact membranes are therefore all needed; one component alone is insufficient. [2]
Why does microcirculation matter too?
The smallest vessels bring blood close to cells. Oxygen and nutrient delivery depend on local flow, vascular regulation and the distance between blood and tissue. Blood properties also matter: red-cell flexibility, reversible aggregation and plasma viscosity. The whole system needs to work together. [1]
Inadequate supply may reduce a tissue’s ability to produce ATP. Inflammation or injury can, in turn, affect vessels and blood cells. This creates a two-way relationship whose course depends on the cause and extent of the problem. Not every brain disorder begins with insufficient blood flow. [1][2]
Heart series: Blood viscosity and microcirculationHuman studies show that PBM can alter haemodynamic markers. Oxygenated haemoglobin, the BOLD signal and blood flow are different measurements, however. A change in one does not automatically establish restored damaged capillaries or better supply throughout the brain. [5][6]
How does light cross the skull, and which wavelength makes sense?
Light is progressively attenuated as it crosses hair, scalp and bone. In 2012, Jagdeo and colleagues compared 633 and 830 nm in a human cadaver head model. Under those conditions, NIR penetrated more effectively than red light. This supports physical feasibility but does not determine the dose in every living person’s brain. [8]
No single best colour has been established for all brain regions and diagnoses. The human studies below used 670, 808, 810 or 1064 nm. Intensity, illuminated area, location and pulsing also matter. Deeper penetration alone does not mean a better clinical outcome. [5][6][7][9][16]
How might red and infrared light affect cells?
Photobiomodulation, or PBM, investigates biological responses to light with specified parameters, particularly red and near-infrared light, NIR. Some light is scattered in tissue and some is absorbed by particular molecules. Absorbing a photon may change their state and trigger further chemical or signalling processes. [2]
One of the most studied candidate photoacceptors is cytochrome c oxidase, CCO, complex IV of the mitochondrial respiratory chain. It participates in electron transfer to oxygen. This is an important proposed mechanism, but a complete explanation of all PBM effects remains under investigation. Light does not replace energy intake from food. [2][4]
How are nitric oxide and oxidative processes involved?
Nitric oxide, NO, is a signalling molecule also important in vascular regulation. One hypothesis proposes that light changes its binding to CCO and thereby affects mitochondrial respiration. This hypothesis should not be presented as a universal explanation. [2][4]
Pope and colleagues studied cultured retinal pigment epithelial cells in 2020. Changes in intracellular NO depended on wavelength, irradiance and metabolic substrate. Their results challenged the idea that releasing NO from CCO alone explains every response. A cell experiment investigates mechanisms; it does not establish treatment of the human brain or eyes. [4]
Reactive oxygen species contribute to signalling within an appropriate range but can damage cell structures in excess. Amount, location and timing all matter. Liu and colleagues’ 2013 review emphasises the cell’s initial state and regulatory capacity. Homeostasis, the maintenance of internal conditions, is a useful framework; it is not evidence that light automatically corrects every dysfunction. [2][3]
Neuroplasticity, BDNF and neuroinflammation
Neuroplasticity is the nervous system’s ability to change connections and functioning; neurogenesis means forming new neurons. Cell and animal studies investigate whether PBM affects BDNF, cell survival and tissue repair. These findings provide a biological rationale for research, but do not prove that home treatment grows new human brain cells. [2]
Microglia are the brain’s immune cells. Their activity is connected to inflammation, energy metabolism and tissue injury. In the mild cognitive impairment study described above, blood IL-6 decreased. That is an interesting inflammatory marker, but neither a direct microglial measurement nor proof that chronic neuroinflammation was eliminated. [2][9]
Why might more light not produce a greater effect?
Experimental models describe a biphasic response: very low and excessively high doses may be less favourable than an intermediate range. That range is not universal. It changes with tissue, wavelength, mode and initial condition. When comparing studies, pay particular attention to these parameters. [2]
Wavelength
It affects light absorption, scattering and penetration in tissue. Red light and different NIR wavelengths are not interchangeable. [2]
Irradiance and time
Average incident irradiance in W/cm² multiplied by time in seconds gives radiant exposure in J/cm². This is not automatically the dose reaching the brain. [2]
Pulses and repetition
Continuous and pulsed delivery, and intervals between sessions, may produce different responses. Equal total energy does not necessarily produce an equal result. [2]
Application site
Skin, skull and other tissues change how much light reaches deeper structures and how it is distributed. [2]
Tissue condition
Supply, metabolism, injury and regulatory mechanisms influence cellular responses. [2]
What have researchers measured in people?
Measuring a physiological response helps investigate a mechanism. Assessing health benefit also requires outcomes that matter to people, such as memory, mood or daily functioning. The following studies illustrate why these levels should be kept distinct. [5][6]
2017 · Wang and colleagues · 11 healthy adults
Researchers applied 1064 nm light to the forehead. Broadband near-infrared spectroscopy detected increases in oxidised CCO and oxygenated haemoglobin signals compared with the control condition. The findings supported investigation of the relationship between metabolic and vascular responses. [5]
What cannot be concluded: The method did not directly measure ATP content. This small study in healthy volunteers also did not test treatment of a particular disease. It reports a physiological response to a specified procedure. [5]
2026 · Iosifescu and colleagues · 31 people with depression
Three 808 nm light settings and a sham condition without active stimulation were compared in random order. One continuous setting increased BOLD signal power, a weaker continuous setting reduced it, and the pulsed setting produced no significant change. Single applications did not significantly improve depression severity compared with sham. [6]
What cannot be concluded: BOLD is a functional MRI signal related to blood oxygenation. A change in it does not directly measure ATP, and a higher signal does not by itself mean better brain function. This summary is based on the published abstract, rather than a full assessment of the methods. [6]
2023 · Fear and colleagues · measuring ATP metabolism
Ten healthy people over 60 entered the study; seven were analysed. Following 670 nm application to the back of the head, phosphorus magnetic resonance spectroscopy detected increased ATP synthase flux. This is an encouraging human finding about energy metabolism, distinct from measuring oxygenation. [7]
The study compared measurements before and after treatment without a sham group. The plan involved four treatment days; two analysed participants had an extended schedule. The small sample and lack of control limit causal conclusions. Measured flux is not the ATP reserve throughout the brain or proof of better thinking. [7]
Memory, attention and brain fog: what did the tests show?
A 2026 randomized pilot included 20 people with mild cognitive impairment. After six weeks of 810 nm stimulation, global cognitive test scores and memory recognition improved more than with sham. This motivates larger research rather than demonstrating the same benefit in healthy students. Some authors had ties to the device manufacturer. [9]
Another 2026 pilot randomized 43 people with post-COVID brain fog and combined transcranial and intranasal application. At eight weeks, the main between-group cognitive difference was not statistically significant (p = 0.088). Some attention tests were favourable, but fatigue favoured sham. The manufacturer funded the study and authors disclosed financial ties. The findings support further testing rather than a promise of rapid relief. [13]
Alzheimer’s disease, Parkinson’s disease, mood and recovery
Neurodegenerative conditions
Small dementia studies have reported favourable changes. A 2017 series of five cases combined transcranial and intranasal light; without a control group, it could not separate treatment effects from other influences. Individual Parkinson’s studies differ, and a 2026 synthesis of controlled trials did not confirm a significant motor-score improvement. These studies also do not demonstrate slower neuronal loss. [14][17]
Depression and anxiety
The 2018 ELATED-2 trial found a favourable depression signal after repeated sessions: its main analysis included 21 people, with 13 completing treatment. Small numbers and incomplete follow-up reduce certainty. The 2026 single-session study described above addressed a different question. Depression findings cannot automatically establish efficacy for an anxiety disorder. [6][10]
Brain injury and stroke
A 2020 randomized trial included 68 people with moderate traumatic brain injury. It found treatment feasible and detected changes in some MRI white-matter measures. The symptom questionnaire difference was not statistically significant. This therefore does not prove faster recovery after every concussion. [11]
For acute ischaemic stroke, the large NEST-3 trial, with 630 randomized patients, did not confirm better functional outcomes for its tested protocol than sham. This applies to that particular acute protocol; other rehabilitation approaches require their own evidence. Sudden speech difficulty, facial droop or limb weakness requires immediate emergency assistance, not home light application. [12]
Are forehead application, nasal application and ILIB equivalent?
No. Transcranial application directs light through the scalp and skull. Intranasal application illuminates the nasal mucosa. Intravenous laser blood irradiation, ILIB, delivers light through an optical fibre into a vein in a medical setting. Each route creates different optical and biological conditions. [2][3]
Research uses local head applicators, helmets or combined transcranial and intranasal application. A combined result does not reveal the nasal applicator’s separate contribution. A standard whole-body LED panel differs in light distribution and dose; devices cannot be treated as interchangeable simply because they list the same nanometres. [13][16][17]
Heart series: Methods of laser blood irradiationSafety, session duration and repetition
Research devices use specified parameters and monitor tolerability. Low power or the term ‘cold laser’ does not guarantee that every use is safe. Excessive exposure can cause heating and eye hazards; invisible NIR gives no reliable bright-light warning. Eye protection must suit the device and wavelength. [15][16]
For a neurological or psychiatric condition, a clinician should assess suitability. Skin and eye conditions, medication and the specific device instructions matter. Stop application if pain, substantial heat or visual symptoms occur. A small study without serious adverse events cannot establish lifelong safety. [9][11][13][15][16]
Research schedules range from a single session to programmes lasting weeks. There is no universal session length or guaranteed time to results. Surface dose depends on average irradiance and time; brain dose also depends on transmission through tissue. Do not increase time or power on your own based on how treatment feels. [7][9][16]
What can readers take from the research?
Meaningful interpretation moves from physics through biochemistry and physiology to clinical outcomes. First ask where the light reaches and what absorbs it. Then ask which cellular or vascular marker changes. Finally ask whether a person’s functioning improves safely and durably. [2][4][5][6]
Feeling tired or experiencing “brain fog” does not itself reveal the amount of ATP in the brain. Similarly, a short-term change in a measured signal does not establish treatment of memory problems or depression. Persistent symptoms deserve assessment of their cause; these studies are not instructions for changing prescribed treatment or configuring home applications. [5][6]
Frequently asked questions
How can light pass through the skull into the brain?
Some light travels through tissue, but much is reflected, scattered or absorbed. The amount depends on wavelength, location and anatomy. [8]
What does light do to mitochondria in neurons?
Researchers mainly study effects on the respiratory chain and cell signalling. CCO is an important proposed light absorber, but not the only possible explanation. [2][4]
Does photobiomodulation increase ATP production in the brain?
A small human study in 2023 measured increased ATP synthase flux. It had no control group; this does not automatically mean more ATP throughout the brain or better memory. [7]
Which wavelength is most suitable for brain stimulation?
No universally best wavelength has been established. Research uses, for example, 670, 808, 810 and 1064 nm with different protocols. [5][6][7][9]
Can light improve memory, attention and concentration?
Some small studies found favourable test results. They do not establish a reliable, lasting benefit for everyone, including healthy students. [9][13]
What has research found about brain fog and fatigue?
A long-COVID pilot found some positive signals, but the main cognitive outcome did not differ significantly from sham. Fatigue improved more in the sham group. [13]
Can light support neuroplasticity and the formation of new neurons?
Cell and animal models support research into BDNF and plasticity. Better test performance or changed oxygenation does not demonstrate new neurons in humans. [2]
Does photobiomodulation affect brain blood flow and oxygenation?
Research has recorded changes in vascular and oxidative markers. Haemoglobin or BOLD signals are not equivalent to directly measuring blood flow or ATP. [5][6]
What have studies found in Alzheimer’s and Parkinson’s disease?
Encouraging pilot findings exist, but they do not demonstrate halted neurodegeneration. Pooled controlled results for Parkinson’s motor symptoms remain inconclusive. [14][17]
Does photobiomodulation help with depression and anxiety?
Small controlled depression trials show a favourable signal. Anxiety requires its own evidence; light does not replace prescribed psychiatric treatment. [6][10]
Can it support recovery after concussion or stroke?
Safety and brain responses are being studied after injury. The large NEST-3 trial did not confirm benefit from its tested laser protocol in acute ischaemic stroke. [11][12]
How are mitochondria, microglia and neuroinflammation connected?
Energy metabolism and immune signalling interact. A change in a blood inflammatory marker alone does not prove reduced inflammation in the brain. [2][9]
How do helmets, nasal applicators and LED panels differ?
They differ in light delivery, illuminated area and dose. Combined head-and-nose treatment does not isolate the nasal applicator’s effect. [13][16][17]
This educational article explains research. Individual diagnosis and treatment require a healthcare professional; specific products are compared in our Advice section.
Next article in the laser series06 · Memory, dementia and photobiomodulation: can light help? →Sources and research
Updated 10 November 2026. Questions, human ATP-metabolism studies and clinical research have been added. Where only an abstract is available, the summary relies on that abstract; cell models, biological markers and clinical outcomes are distinguished.
- Baskurt OK, Hardeman MR, Rampling MW, Meiselman HJ, eds. Handbook of Hemorheology and Hemodynamics. IOS Press; 2007.
Open source - Salehpour F et al. Brain Photobiomodulation Therapy: a Narrative Review. Molecular Neurobiology. 2018;55:6601–6636. DOI: 10.1007/s12035-017-0852-4.
Open source - Liu TCY, Li XE, Liu SH. Photobiomodulation – The Chinese approaches and advances in clinical application. Photonics & Lasers in Medicine. 2013;2(1):19–26. DOI: 10.1515/plm-2012-0037.
Open source - Pope NJ, Powell SM, Wigle JC, Denton ML. Wavelength- and irradiance-dependent changes in intracellular nitric oxide level. Journal of Biomedical Optics. 2020;25(8):085001. DOI: 10.1117/1.JBO.25.8.085001.
Open source - Wang X et al. Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: A broadband near-infrared spectroscopy study. Journal of Cerebral Blood Flow & Metabolism. 2017;37(12):3789–3802. DOI: 10.1177/0271678X17691783.
Open source - Iosifescu DV et al. Dose dependent effects of transcranial photobiomodulation on blood-oxygenation-level-dependent power in major depressive disorder. Brain Stimulation. 2026;19(5):103185. DOI: 10.1016/j.brs.2026.103185.
Open source - Fear EJ et al. Use of 31P magnetisation transfer magnetic resonance spectroscopy to measure ATP changes after 670 nm transcranial photobiomodulation in older adults. Aging Cell. 2023;22:e14005. DOI: 10.1111/acel.14005.
Open source - Jagdeo JR et al. Transcranial Red and Near Infrared Light Transmission in a Cadaveric Model. PLoS ONE. 2012;7:e47460. DOI: 10.1371/journal.pone.0047460.
Open source - Rashidi-Ranjbar N et al. A multimodal evaluation of transcranial photobiomodulation in mild cognitive impairment: Cognitive, metabolic, and neuroimaging outcomes of a pilot randomized controlled trial. Journal of Alzheimer’s Disease. 2026. DOI: 10.1177/13872877261453911.
Open source - Cassano P et al. Transcranial Photobiomodulation for the Treatment of Major Depressive Disorder. The ELATED-2 Pilot Trial. Photomedicine and Laser Surgery. 2018;36:634–646. DOI: 10.1089/pho.2018.4490.
Open source - Figueiro Longo MG et al. Effect of Transcranial Low-Level Light Therapy vs Sham Therapy Among Patients With Moderate Traumatic Brain Injury: A Randomized Clinical Trial. JAMA Network Open. 2020;3:e2017337. DOI: 10.1001/jamanetworkopen.2020.17337.
Open source - Hacke W et al. Transcranial laser therapy in acute stroke treatment: results of neurothera effectiveness and safety trial 3, a phase III clinical end point device trial. Stroke. 2014;45:3187–3193. DOI: 10.1161/STROKEAHA.114.005795.
Open source - Photobiomodulation for cognitive dysfunction (Brain Fog) in post-COVID-19 condition: a randomized double-blind sham-controlled pilot trial. 2026. PMID: 41768981.
Open source - Mariano J et al. Efficacy and Safety of Photobiomodulation Therapy for Motor Symptoms in Parkinson’s Disease: A Systematic Review and Meta-Analysis. Brain Sciences. 2026;16:925. DOI: 10.3390/brainsci16090925.
Open source - U.S. Food and Drug Administration. Frequently Asked Questions About Lasers.
Open source - Zein R, Selting W, Hamblin MR. Review of light parameters and photobiomodulation efficacy: dive into complexity. Journal of Biomedical Optics. 2018;23:120901. DOI: 10.1117/1.JBO.23.12.120901.
Open source - Saltmarche AE et al. Significant Improvement in Cognition in Mild to Moderately Severe Dementia Cases Treated with Transcranial Plus Intranasal Photobiomodulation: Case Series Report. Photomedicine and Laser Surgery. 2017;35:432–441. DOI: 10.1089/pho.2016.4227.
Open source











